Avecho Biotechnology Limited (ASX:AVEOA)

Australia flag Australia · Delayed Price · Currency is AUD · Option
0.0010
0.00 (0.00%)
At close: Mar 6, 2026
Market Cap22.21M +133.6%
Revenue (ttm)1.38M +306.9%
Net Income-3.62M
EPS-0.00
Shares Outn/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume5,000,000
Average Volume2,977,552
Open0.0010
Previous Close0.0010
Day's Range0.0010 - 0.0010
52-Week Range0.0010 - 0.0020
Betan/a
RSI48.03
Earnings DateNov 28, 2025

About Avecho Biotechnology

Avecho Biotechnology Limited, a biotechnology company, develops and commercializes human and animal health products using its proprietary drug delivery system, tocopherol phosphate mixture (TPM) in Australia, Switzerland, France, and India. It operates through Production and Human Health segments. The company manufactures and sells TPM and Vital ET products for use in drug delivery and cosmetic formulations. Its human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. In addition, the company dev... [Read more]

Industry Pharmaceutical Preparations
Founded 1992
Employees 15
Stock Exchange Australian Securities Exchange
Ticker Symbol AVEOA
Full Company Profile